The National Institute of Health Policy

 Briefing

 

 

 

 

 

 

Volume 2, Number 2

 

April 21, 2004

 

 

Tom Scully on the Medicare Modernization Act 2003

Dave Durenberger Introduces Tom Scully

While Democrats in Washington D.C. were trying to subpoena the former CMS administrator, he was at the St. Paul Hotel with a couple hundred friends of NIHP. On April 5th, Tom Scully was “on travel” to D.C. reporters, while in St. Paul explaining in frank detail the architecture of and the various roles played by architect of the Medicare Modernization Act (MMA) of 2003.  Even those of us who disagree with parts of MMA as good policy for good practice, are now among the few in this country who understand why it happened as it did.

Tom Scully is now a partner in the Washington Law firm of Alston and Bird and of an investment firm in New York City.  He cannot lobby his former CMS colleges for a year. He said he does benefit from having an office at Alston that is next door to former Senate Leader and former GOP Presidential Candidate Bob Dole.

Scully presented and answered questions before an audience of 170 for more than one hour and spent another few hours with members of NIHP answering their questions. When we receive it, his PowerPoint presentation to the public event will be posted on our web site.  The following is a highlighted summary of both of the Scully presentations courtesy of the work of our colleague Sheila Delaney Moroney.  The narrative reflects the comments of Mr. Scully and, in most cases, are direct quotes.  Sheila, like every one else in the room observed that Scully “talks faster than anyone I’ve ever met”.

We at the College of Business of the University of St. Thomas are grateful to all who participated in this event, and to all the NIHP members whose financing made it possible.  

Notes from Tom Scully's Public Remarks

Tom Scully's Opening Comments on the MMA

  • Three people were chief architects: Tom Scully, CMS administrator, Doug Badger, White House counsel, and Mark McClellan, FDA administrator, now CMS administrator.
  • Medicare prices are exploding – with or without drugs.  The system needs competition to control cost drivers which include an aging population; an insatiable desire to build new things; and, increasing costs of health care goods and services.
  • This is a very good bill for poor seniors.
  • The bill will save seniors money by reducing the need for medi-gap and drug supplementals, and offers an alternative to government price-fixing.
  • Rx spending will dominate Medicare policy decisions starting in 2006.  At present, no one at CMS/Medicare has drug expertise.  It will take a significant amount of time to ramp up the right staff and thus “it will take some time to get your questions answered.  They have to build agency expertise in this area.”
  • The 4% administrative costs associated with Medicare efficiency are correct.  We have very low administrative costs, compared to the private plans, but all we really are is an efficient check-writing machine.  We are flying blind.  It will be a lot better to pay a plan for 8-9% in administrative costs and really know what is going on.

 Provider Issues

  • The average hospital gets 65% of payments from government payers, 30% from private insurance and 5% is charity care.  Where is the incentive for hospitals to change when the single largest payer fixes the rates?  Congress and this administration intend to move to a system in which 65% of people are in private plans and price and quality are differentiated.  There is no motivation for behavior change when prices are fixed by the government.

Beneficiary Issues

  • This is a giant benefit for people who need it.  The donut hole only affects those who can afford it, and even then, there is a $1400 subsidy for high-income people.  “It still burns me that people like Bill Gates’ father will get a $1400/year inflated subsidy.”
  • Low-income people have 1st dollar coverage with 1984 deductibles. This is a massive revolution in your life if you are low income. (Represents 10-11 million people). This is the biggest thing that has happened to poor seniors since  SSA.  In fact, I think we might have overdone it and I predict massive over utilization.
  • AARP, the beneficiary’s advocate, supported this effort because “they saw it as the only train to get on in the next 10 years.”

Medicare Advantage vs. Medicare Original

  • Medigap is generally a mess and provides a very thin benefit.  The new Medicare program, which will be available in 2006, will blend the best of all the fragmented options—Original Medicare + Drugs + Medigap—that seniors have today into one plan.
  •  The new option can be likened to a Blue Cross Blue Shield-like PPO.  A loosely designed network model has taken over the US but is not currently available in Medicare.  Medicare Advantage will be one community-rated product with one design that looks a lot like what most people (70% of country) are buying through age 64.  Why should you lose the option to choose once you are 65?
  •  (Scully referred to Department of Defense Health Program TriCare as model for regional plan design).  MMA might advantage the bigger plans, but the design allows for smaller plans to collaborate to bid for the business and offer a package; the model to look at is TriWest Health Alliance out of Phoenix, AZ.
  •  The strength of the regional design is that it prevents the large plans from cherry-picking the most lucrative counties and forces them to offer the same community-rated benefit to every community across their region.
  •  Among the 15 currently proposed regions, the Upper Midwest region includes MN, WI, SD, ND, and MI.
  •  “In a perfect market the doctors, plans, and hospitals should all hate each other a little bit.  No one should have too much power or it corrupts the market.”

 Drug Prices and the Drug Card

  • The fundamental problem is that seniors are cost-shifted against in the health care system in a big way.  The under-65 population gets the benefit of group purchasing for drugs.  Seniors buy in a “group of one.”  The drug card will allow seniors to get together into a group purchasing cooperative through the discount drug card—a “small but helpful step.” 
  • The $600 subsidy coming to low-income seniors in June, 2004 should be a huge help.
  • The federal government has 50% of the market share, and in some cases 95% of the market share.  With that leverage, the government is not negotiating prices they are fixing prices.  We had to break up the market into big chunks to achieve fair price negotiation.  If the government was to be in the price fixing business for drugs, it would be a 100% political process.
  • The government has to provide food, housing and healthcare, but we don’t fix prices for the first two.  Healthcare should be a consumer good with competition over price, quality, and consumer satisfaction.
  • PBMs cannot afford not to get into this business.  We are counting on vastly increased price transparency and complete disclosure about rebates.  Drug companies will have very low prices and will make their money off of high volume. 
  • The drug money in this bill will initially foster high over utilization of drugs by seniors.  There is no way around it.
  • CMS will implement drug tiering for the discount card plans, which will control and change behavior.  Today, the FDA approves a drug and it becomes widely available no matter what it’s therapeutic advantage.  In the future there will have to be some debate about  where a particular drug falls on the formulary.

Give Backs

  • There was no other way to keep large employers from dropping their drug benefit plans for retirees except to give them a huge buy-out.  GM, for example, should see about $3000/head.

 Clawbacks

  • This is also a giant buy out for the states.  It will be a significant windfall for every state—some more than others—but no one will lose.  There are really big winners and winners. 

 Quality and Disease Management

  • Disease management will be a huge emphasis for CMS.  Of the $300 billion that Medicare spends, $200 billion is Fee-for-Service (FFS).  But, there is no incentive in FFS to change behavior.  The MMA will establish disease management demonstrations on the FFS side.  We know that a diabetic will cost $65K in a given year.  The demonstrations will give the money to the disease management companies and put them at risk for the outcomes.

Provider Issues

  • Hospitals and physicians should be worried about the deficit.  Congress will be looking to trim $140 billion from the budget and hospitals and physicians are likely to be the target.  They will be looking at a payment rate that is not full market basket for hospitals.  These will be painful times for provider organizations.
  • In 10 years, the market will be driven by private payers rather than  through government price fixing.
  • Medicare should be a boring, low margin business.  Historically, Medicare financing has kept providers on a financing roller coaster that creates great uncertainty and stress.  If you are running a hospital, you should not have to worry about any Medicare bill currently in Congress. 
  • We will eventually have to correct the flawed formula that resulted in a huge physician payment mistake that Congress made in 1997. Rather than taking the time and money it will cost to redo the formula now, Congress will continue to move the eventual payment rate cut out two years.

Notes from Member Lunch with Tom Scully

These notes reflect questions posed by NIHP members and Mr. Scully’s response to those questions.  Member questions are in italics.

Medicare Advantage vs. Medicare Original

  • Medigap:  The bill obviates the option to offer  Medigap coverage.  What are you offering as an alternative that will work in MN where Medigap is very popular (there are 170,000 enrollees at BCBS, for example)?

TS:  You might be able to get a waiver to still offer Medigap in MN but you won’t get it for drugs.

  • Risk Segmentation:  How does this bill address risk segmentation?

TS:  CMS currently has 70 risk-adjusted categories, but in three years, when the whole bill is rolled out, risk selection and cherry picking will not be rewarded.

  • Regional competition:  Local plans are concerned about big plans being incented to enter a region, low-balling prices in that region and thus jeopardizing our ability to do business.

TS:  You will certainly be able to operate as a local plan unchanged.  Some consultants will be running around and trying to patch together plans for bidding against the nationals.  TriWest is an example.  Regional cooperatives will be popular and PPOs will be hotly competitive.  From 2006-2010 we are just offering them some extra money to get them up and going.

CMS will be very sympathetic to regional cooperation among local plans.  Though it is also important to get the big plans into a region in order to ensure choice.

The big players will have to make a huge investment to get into a region and will be less than enthusiastic to leave once they have done so.  Unlike the current system, there will be no incentive for the big plans to cherry pick and move in and out of a market on a whim.

The regional plans will ideally want to partner with the local HMOs and take advantage of their delivery system’s efficiency and lower cost of care.

  • Defining the regions:  What criteria were used to define the regions?

TS:  We looked for natural markets where people would be likely to do business together.  FEHBP (Federal Employee Health Benefits Plan), with 8 million enrollees, is a fairly good model.  It represents one national region where the Blues make transfer payments among regions.  MMA regions build on the strengths and successes of the FEHBP model.

We split up the country to ensure plan entry into the Rocky Mountain States. We want everyone, even in the most remote areas, to have access to Medicare Advantage.

Quality

  • Quality:  Is there a move towards differential payment for quality in the FFS Medicare world?

TS:  I love the idea of paying differentially for quality but, through Premier, we had to drag the hospitals kicking and screaming to get acceptance for a 1% payment adjustment based on outcomes.  Differential payment in FFS is a great idea but so far all we've been able to accomplish is modified price fixing.

  • Pay for Performance demonstrations:  Does CMS have the capability to figure out how to generalize and institutionalize successful demos?

TS:  No, CMS is not a big policy-making apparatus. 

Beneficiary Issues

  • Medicare payment equity:  We are getting shortchanged for doing the right thing.

TS:  What can you do about it?  Everybody should practice medicine like you do in Minneapolis and in Seattle.  You should be happy with the 84% subsidized benefit that you do get.  Complaining about geographic inequity is not going to make it go away.  Keep in mind that there is a difference in the cost of doing business in New York compared to Minnesota.  One possible hope is that consumer-driven efforts to drive change will reform the high-volume states.  

  • Fairness:  What about the 56,000 retirees who are slated to lose their drug coverage in Minnesota? 

TS:  They will lose it more slowly because of this bill. 

  • Out-of-pocket spending:  Some seniors will be worse off in terms of out of pocket spending with the MMA than with their current plans.

TS: There is nothing for seniors to be upset about except that their children will have to pay more taxes.  The only other people who might be mad about the $400 billion we are spending on this bill, are the hard-working laborers whose taxes are still going to subsidize the benefits of rich seniors.  I am happy to pay taxes for the drugs of poor people, but I am not happy to send a check to a rich person playing golf in Naples—which is what this bill’s designed will do.

Provider Issues:

  • Provider consolidation:  Will MMA drive further consolidation of provider organizations?

TS:  This is not a model that will impact provider organizations.  It will, however, force a consolidation of plans.

Dave Durenberger’s concluding comments:

  • I would like to compliment Tom for his conviction and service.

  • I would feel better about getting my health care from a doctor in MN instead of from a national corporation.  The fundamental question is whom do we trust to change behavior?

  • In MN we have taken care of each other for a long time.  The evidence is our 4.9% uninsured rate and our near universal access.  Compare that to TX at 24% uninsured and we know we don’t want to be like the other states.  You have designed a national solution that I can’t completely discount, but what you have heard stressed today by NIHP leaders in five states is that one size does not fit all.

  • What is the Bush administration’s policy on Medicaid, the uninsured and long term care?  What are we likely to see in terms of national support for MN, WI, and the rest of the UMW states for our Medicaid programs?

Tom Scully’s response to D. Durenberger

  • There will be plenty of opportunity to roll back pieces of MMA.  We have only changed the direction of this ship by two degrees.

  • If I had my way, we would have taken care of the issue of the uninsured first but I think that Medicaid reform is impossible.  There are 50 different deals in 50 different states.  It all comes down to money and if you separate acute care from LTC, half the states will win and half will lose depending on which way you split it.

  • We have slowly, quietly begun to deregulate Medicare and make it a good thing.  But the under 65 market is a disaster.  We can pay for the uninsured without more money.  I think we should get rid of ERISA.  and get rid of insurance rules that keep people out of the system.  We spend $35 billion on care for the uninsured in the system we have.  It would only cost $30 billion more to cover everyone.  The people in this room are over-subsidized and the poor people who are not here are under-subsidized.  No one has the guts to put a cap on tax subsidies.  There is plenty of money in the system, it is just maldistributed. 

 

Your thoughts and opinions are welcome on the Tom Scully event and on MMA 2003 in general.  As always, if you have any questions or comments, please contact me: E-mail Dave Durenberger or sign on to our website:  www.NIHP.org and click on the discussion link to contribute your opinion.

Links to Information about the Medicare Drug Bill

Medicare Trustees Report

http://www.ssa.gov/OACT/TRSUM/tr04summary.pdf

HHS Drug Discount Card Press Release

http://www.cmwf.org/programs/healthbeat15.asp#seniors

Medicare Rights Center

 http://www.medicarerights.org